DOI QR코드

DOI QR Code

Interoperative Radiotherapy of Seventy-two Cases of Early Breast Cancer Patients During Breast-conserving Surgery

  • Zhou, Shi-Fu (Center of Breast Diseases, the Fourth Peoples Hospital of Wuxi City) ;
  • Shi, Wei-Feng (Center of Breast Diseases, the Fourth Peoples Hospital of Wuxi City) ;
  • Meng, Dong (Center of Breast Diseases, the Fourth Peoples Hospital of Wuxi City) ;
  • Sun, Chun-Lei (Center of Breast Diseases, the Fourth Peoples Hospital of Wuxi City) ;
  • Jin, Jian-Rong (Department of Radiotherapy, the Fourth Peoples Hospital of Wuxi City) ;
  • Zhao, Yu-Tian (Department of Radiotherapy, the Fourth Peoples Hospital of Wuxi City)
  • Published : 2012.04.30

Abstract

Objective: To evaluate interoperative radiotherapy after breast conservative surgery in early breast cancer patients in terms of postoperative complications, cosmetic outcome and recurrence events. Methods: From June 2007 to Dec 2011, 143 early breast cancer patients received breast conservative surgery. Seventy-two (study group) received interoperative radiotherapy, compared with 71 patients (control group) given routine radiotherapy. Postoperative complications were evaluated 1 month after surgery; cosmetic outcome was evaluated 1 year postoperatively; recurrence and death events were followed up. Results: The average wound healing time was 13~22 d in the study group and 9~14 d in the control group. In the study group, 2 patients developed lyponecrosis, 16 patients showed wound edema while no such side effects were found in the control group. No infection or hematomas were found in either group. In the study group (59 cases), overall cosmetic outcome in 53 patients was graded as excellent or good, and in 6 as fair or poor. Meanwhile in the control group (56 cases), 42 patients were graded as excellent or good, and 14 as fair or poor (P=0.032). After a follow-up from 3 to 54 months (median: 32 months), two patients (2.78%) in study group developed local relapses, one of them (1.39%) died, 2 patients (2.78%) developed bone metastases. In control group, one patient (1.41%) developed local relapse, 2 patients (2.82%) developed bone metastases, and no one died. Conclusion: Intraoperative radiotherapy is safe and reliable with good cosmetic outcome.

Keywords

References

  1. Abbott AM, Habermann EB, Tuttle TM (2011). Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer, 117, 3305-10. https://doi.org/10.1002/cncr.25927
  2. Beal K, McCormick B, Zelefsky MJ, et al (2007). Single-fraction inttraoperative radiotherapy for breast cancer: early cosmetic results. Int J Radiat Oncol Biol Phys, 69, 19-24. https://doi.org/10.1016/j.ijrobp.2007.02.010
  3. Dubois JB, Hay M, Gely S, et al (1997). IORT in breast carcinomas. Front Radiat Ther Oncol, 31, 131-7. https://doi.org/10.1159/000061160
  4. Fisher B, Jeong JH, Anderson S, et al (2002). Twenty-fiveyear follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med, 347, 567-75. https://doi.org/10.1056/NEJMoa020128
  5. Intra M, Gatti G, Luini A, et al (2002). Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg, 137, 737-40. https://doi.org/10.1001/archsurg.137.6.737
  6. Intra M, Luini A, Gatti G, et al (2006). Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: A lesson learned by over 1000 procedures. Surgery, 140, 467-71. https://doi.org/10.1016/j.surg.2006.03.019
  7. Luini A, Orecchia R, Gatti G, et al (2005). The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat, 93, 55-9. https://doi.org/10.1007/s10549-005-3782-1
  8. Perera F, Engel J, Holliday R, et al (1997). Local resection and brachy therapy confined to the lumpectomy site for early breast cancer: A pilot study. J Surg Oncol, 65, 263-7. https://doi.org/10.1002/(SICI)1096-9098(199708)65:4<263::AID-JSO7>3.0.CO;2-3
  9. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS (1993). The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol, 5, 5278-83.
  10. Sawaki M, Sato S, Kikumori T, et al (2009). A Phase I Study of Intraoperative Radiotherapy for Early Breast Cancer in Japan. World J Surg, 33, 2587-92. https://doi.org/10.1007/s00268-009-0227-8
  11. Veronesi U, Cascinelli N, Mariani L, et al (2002). Twentyyear follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer. N Engl J Med, 347, 1227-32. https://doi.org/10.1056/NEJMoa020989
  12. Veronesi U, Galimberti V, Zurrida S, et al (2001). Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer, 37, 454-8. https://doi.org/10.1016/S0959-8049(00)00410-X
  13. Veronesi U, Gatti G, Luini A, et al (2003). Full-dose intraoperative radiotherapy with electrons during breastconserving surgery. Arch Surg, 138, 1253-6. https://doi.org/10.1001/archsurg.138.11.1253
  14. Veronesi U, Gatti G, Luini A, et al (2003). Intraoperative radiotherapy for breast cancer:technical notes. Breast J, 9, 106-12. https://doi.org/10.1046/j.1524-4741.2003.09208.x
  15. Veronesi U, Marubini E, Mariani L, et al (2001). Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol, 12, 997-1003. https://doi.org/10.1023/A:1011136326943
  16. Veronesi U, Orecchia R, Luini A, et al (2001). A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer, 37, 2178-83. https://doi.org/10.1016/S0959-8049(01)00285-4
  17. Veronesi U, Orecchia R, Luini A, et al (2001). Focalized intraoperative irradiation after conservative surgery for early-stage breast cancer. Breast, 10, 84-9. https://doi.org/10.1054/brst.2000.0193
  18. Veronesi U, Orecchia R, Luini A, et al (2005). Full-dose intraoperative radiotherapy with electrons during breastconserving surgery experience with 590 cases. Ann Surg, 242, 101-6. https://doi.org/10.1097/01.sla.0000167927.82353.bc
  19. Veronesi U, Paganelli G, Galimberti V, et al (1997). Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet, 349, 1864-7. https://doi.org/10.1016/S0140-6736(97)01004-0
  20. Vicini F, Kini VR, Chen P, et al (1999). Irradiation of the tumor bed alone after lumpectomy in selected patients with earlystage breast cancer treated with breast conserving therapy. J Surg Oncol, 70, 33-40. https://doi.org/10.1002/(SICI)1096-9098(199901)70:1<33::AID-JSO6>3.0.CO;2-O

Cited by

  1. Effect of Botulinum Toxin A on Proliferation and Apoptosis in the T47D Breast Cancer Cell Line vol.14, pp.2, 2013, https://doi.org/10.7314/APJCP.2013.14.2.891
  2. Benefit of Post-mastectomy Radiotherapy of the Supra-/infraclavicular Lymphatic Drainage Area in Breast Cancer Patients vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5557
  3. Awareness and current knowledge of breast cancer vol.50, pp.1, 2017, https://doi.org/10.1186/s40659-017-0140-9
  4. Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer vol.109, pp.8, 2014, https://doi.org/10.1002/jso.23581
  5. Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy in Early-Stage Breast Cancer vol.94, pp.27, 2015, https://doi.org/10.1097/MD.0000000000001143
  6. Intraoperative boost radiation effects on early wound complications in breast cancer patients undergoing breast-conserving surgery vol.47, pp.13036165, 2017, https://doi.org/10.3906/sag-1605-48